Recent additions may not be included but will usually appear in 24 hrs or less.
Rational | Source |
---|---|
Doenjang, a fermented Korean soybean paste, inhibits lipopolysaccharide production of gut microbiota in mice. β
Go to Publication β
Journal of medicinal food (J Med Food ) Vol: 17 Issue 1 Pages: 67-75 Pub: 2014 Jan Epub: Authors Jang SE , Kim KA , Han MJ , Kim DH , |
|
Doenjang, a fermented Korean soybean paste, inhibits lipopolysaccharide production of gut microbiota in mice. β
Go to Publication β
Journal of medicinal food (J Med Food ) Vol: 17 Issue 1 Pages: 67-75 Pub: 2014 Jan Epub: Authors Jang SE , Kim KA , Han MJ , Kim DH , |
|
Doenjang, a fermented Korean soybean paste, inhibits lipopolysaccharide production of gut microbiota in mice. β
Go to Publication β
Journal of medicinal food (J Med Food ) Vol: 17 Issue 1 Pages: 67-75 Pub: 2014 Jan Epub: Authors Jang SE , Kim KA , Han MJ , Kim DH , |
|
Influence of fermented soy protein consumption on hypertension and gut microbial modulation in spontaneous hypertensive rats. β
Go to Publication β
Bioscience of microbiota, food and health (Biosci Microbiota Food Health ) Vol: 39 Issue 4 Pages: 199-208 Pub: 2020 Epub: 2020 May 14 Authors Daliri EB , Ofosu FK , Chelliah R , Lee BH , An H , Elahi F , Barathikannan K , Kim JH , Oh DH , |
|
Influence of fermented soy protein consumption on hypertension and gut microbial modulation in spontaneous hypertensive rats. β
Go to Publication β
Bioscience of microbiota, food and health (Biosci Microbiota Food Health ) Vol: 39 Issue 4 Pages: 199-208 Pub: 2020 Epub: 2020 May 14 Authors Daliri EB , Ofosu FK , Chelliah R , Lee BH , An H , Elahi F , Barathikannan K , Kim JH , Oh DH , |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.